[Subclinical thyroid disease].
Subclinical thyroid dysfunction is a frequent disorder characterized by abnormal levels of thryotropin (TSH) and normal thyoid hormones. Subclinical hypothyroidism can be associated with unspecific symptoms and dyslipidemia, a substitution is generally recommended if the TSH is > 10 microU/l. With lower TSH-levels, the indication for substitution is individual, depending on other risk factors or diseases like dyslipidemia, smoking, goiter, pregnancy or clinical symptoms. Subclinical hyperthyrodism is a risk factor for atrial fibrillation and reduced bone mass densitiy. A diagnostic and therapeutic approach should be performed individually.
Stöckli
R
R
Medizinische Poliklinik, Universitätsspital Basel. R.Stoeckli@uhbs.ch
D000328:Adult; D000367:Age Factors; D000368:Aged; D013956:Antithyroid Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000453:epidemiology; D015519:Bone Density; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D007037:Hypothyroidism / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D015994:Incidence; D008297:Male; D011247:Pregnancy; D012307:Risk Factors; D012907:Smoking / Q000453:epidemiology; D013959:Thyroid Diseases / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D013963:Thyroid Hormones / Q000097:blood; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
D013956:Antithyroid Agents; D013963:Thyroid Hormones; D013972:Thyrotropin; D013974:Thyroxine